Laurus Labs Limited
LAURUSLABS
Rang in Aktien
#1744
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aktienkurs
$22.80
Marktkapitalisierung
$12.32B
Veränderung (1 Tag)
0.36%
Veränderung (1 Jahr)
122.99%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategorie
Healthcare
EPS für Laurus Labs Limited (LAURUSLABS)
EPS zum June 2026 TTM: $0.22
Laut den aktuellen Finanzberichten und dem Aktienkurs von Laurus Labs Limited beträgt das aktuelle EPS des Unternehmens (TTM) $0.22. Am Ende des Jahres 2024 betrug das EPS $0.04 ein Rückgang im Vergleich zu dem EPS von 2023, das $0.18 betrug.
EPS-Verlauf von Laurus Labs Limited von 2013 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.22 | 179.38% |
| 2025 | $0.08 | 117.93% |
| 2024 | $0.04 | -80.03% |
| 2023 | $0.18 | -11.96% |
| 2022 | $0.20 | -19.02% |
| 2021 | $0.25 | 294.34% |
| 2020 | $0.06 | 149.41% |
| 2019 | $0.03 | -47.64% |
| 2018 | $0.05 | -24.02% |
| 2017 | $0.06 | -0.62% |
| 2016 | $0.06 | 82.20% |
| 2015 | $0.04 | -4.07% |
| 2014 | $0.04 | -30.64% |
| 2013 | $0.05 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 148.90% |
IN
|
